April D. Harrison

662 total citations
13 papers, 599 citations indexed

About

April D. Harrison is a scholar working on Molecular Biology, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, April D. Harrison has authored 13 papers receiving a total of 599 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in April D. Harrison's work include Thyroid Cancer Diagnosis and Treatment (4 papers), Neuroendocrine Tumor Research Advances (3 papers) and Lung Cancer Research Studies (3 papers). April D. Harrison is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (4 papers), Neuroendocrine Tumor Research Advances (3 papers) and Lung Cancer Research Studies (3 papers). April D. Harrison collaborates with scholars based in United States and Italy. April D. Harrison's co-authors include Herbert Chen, Renata Jaskula‐Sztul, Ajitha Dammalapati, Shaoqin Gong, Guojun Chen, Weiping Tang, Muthusamy Kunnimalaiyaan, Xiao-Min Yu, Yi‐Qiang Cheng and Irene Lou and has published in prestigious journals such as Biomaterials, Advanced Functional Materials and American Journal Of Pathology.

In The Last Decade

April D. Harrison

13 papers receiving 598 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
April D. Harrison United States	11	272	180	135	106	101	13	599
Martin Ullrich Germany	17	248 0.9×	97 0.5×	167 1.2×	61 0.6×	131 1.3×	55	835
Tsang-Pai Liu Taiwan	15	348 1.3×	147 0.8×	89 0.7×	132 1.2×	34 0.3×	23	747
Wenjie Feng China	14	220 0.8×	172 1.0×	41 0.3×	102 1.0×	54 0.5×	30	646
Cale D. Fahrenholtz United States	13	187 0.7×	205 1.1×	59 0.4×	131 1.2×	86 0.9×	24	530
Chenshi Lin China	8	236 0.9×	219 1.2×	51 0.4×	75 0.7×	46 0.5×	18	582
Valentina Belli Italy	18	294 1.1×	134 0.7×	173 1.3×	105 1.0×	14 0.1×	46	748
Li Tu China	14	218 0.8×	171 0.9×	96 0.7×	78 0.7×	15 0.1×	27	580
Guihua Jiang China	13	165 0.6×	237 1.3×	89 0.7×	116 1.1×	40 0.4×	52	715
Ajitha Dammalapati United States	9	195 0.7×	219 1.2×	72 0.5×	116 1.1×	17 0.2×	12	475

Countries citing papers authored by April D. Harrison

Since Specialization

Citations

This map shows the geographic impact of April D. Harrison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by April D. Harrison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites April D. Harrison more than expected).

Fields of papers citing papers by April D. Harrison

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by April D. Harrison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by April D. Harrison. The network helps show where April D. Harrison may publish in the future.

Co-authorship network of co-authors of April D. Harrison

This figure shows the co-authorship network connecting the top 25 collaborators of April D. Harrison. A scholar is included among the top collaborators of April D. Harrison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with April D. Harrison. April D. Harrison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Lou, Irene, et al.. (2017). Notch3 as a novel therapeutic target in metastatic medullary thyroid cancer. Surgery. 163(1). 104–111. 6 indexed citations

Jang, Samuel, Matthew B. Robers, April D. Harrison, et al.. (2017). Histone deacetylase inhibitor thailandepsin-A activates Notch signaling and suppresses neuroendocrine cancer cell growthin vivo. Oncotarget. 8(41). 70828–70840. 9 indexed citations

Chen, Guojun, Renata Jaskula‐Sztul, Corinne R. Esquibel, et al.. (2017). Neuroendocrine Tumor‐Targeted Upconversion Nanoparticle‐Based Micelles for Simultaneous NIR‐Controlled Combination Chemotherapy and Photodynamic Therapy, and Fluorescence Imaging. Advanced Functional Materials. 27(8). 158 indexed citations

Jaskula‐Sztul, Renata, Wenjin Xu, Guojun Chen, et al.. (2016). Thailandepsin A-loaded and octreotide-functionalized unimolecular micelles for targeted neuroendocrine cancer therapy. Biomaterials. 91. 1–10. 55 indexed citations

Hardin, Heather, Xiao-Min Yu, April D. Harrison, et al.. (2016). Generation of Novel Thyroid Cancer Stem-Like Cell Clones. American Journal Of Pathology. 186(6). 1662–1673. 27 indexed citations

Chen, Guojun, Renata Jaskula‐Sztul, April D. Harrison, et al.. (2016). KE108-conjugated unimolecular micelles loaded with a novel HDAC inhibitor thailandepsin-A for targeted neuroendocrine cancer therapy. Biomaterials. 97. 22–33. 44 indexed citations

Jaskula‐Sztul, Renata, Guojun Chen, Ajitha Dammalapati, et al.. (2016). AB3-loaded and tumor-targeted unimolecular micelles for medullary thyroid cancer treatment. Journal of Materials Chemistry B. 5(1). 151–159. 23 indexed citations

Jaskula‐Sztul, Renata, Jacob G. Eide, Ajitha Dammalapati, et al.. (2014). Tumor-Suppressor Role of Notch3 in Medullary Thyroid Carcinoma Revealed by Genetic and Pharmacological Induction. Molecular Cancer Therapeutics. 14(2). 499–512. 38 indexed citations

Harrison, April D., et al.. (2014). The novel histone deacetylase inhibitor thailandepsin A inhibits anaplastic thyroid cancer growth. Journal of Surgical Research. 190(1). 191–197. 26 indexed citations

10.

Hardin, Heather, Zhenying Guo, Weihua Shan, et al.. (2014). The Roles of the Epithelial-Mesenchymal Transition Marker PRRX1 and miR-146b-5p in Papillary Thyroid Carcinoma Progression. American Journal Of Pathology. 184(8). 2342–2354. 87 indexed citations

11.

Jaskula‐Sztul, Renata, et al.. (2013). Resveratrol Induces Differentiation Markers Expression in Anaplastic Thyroid Carcinoma via Activation of Notch1 Signaling and Suppresses Cell Growth. Molecular Cancer Therapeutics. 12(7). 1276–1287. 95 indexed citations

12.

Burke, Jocelyn F., et al.. (2013). MK-2206 Causes Growth Suppression and Reduces Neuroendocrine Tumor Marker Production in Medullary Thyroid Cancer Through Akt Inhibition. Annals of Surgical Oncology. 20(12). 3862–3868. 10 indexed citations

13.

Harrison, April D., et al.. (2012). Neuroendocrine phenotype alteration and growth suppression through apoptosis by MK-2206, an allosteric inhibitor of AKT, in carcinoid cell lines in vitro. Anti-Cancer Drugs. 24(1). 66–72. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact